A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice

Doxorubicin (Dox) is approved for use in liposomal form for the treatment of ovarian cancer. We previously developed a long-circulating Dox formulation in liposomes containing small amounts of porphyrin-phospholipid, which enables on-demand drug release with near-infrared irradiation. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kress, Jeremy, Rohrbach, Daniel J., Carter, Kevin A., Luo, Dandan, Poon, Chien, Aygun-Sunar, Semra, Shao, Shuai, Lele, Shashikant, Lovell, Jonathan F., Sunar, Ulas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686102/
https://www.ncbi.nlm.nih.gov/pubmed/29138489
http://dx.doi.org/10.1038/s41598-017-15790-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686102/
https://www.ncbi.nlm.nih.gov/pubmed/29138489
http://dx.doi.org/10.1038/s41598-017-15790-y

Ejemplares similares